Rita Rachmani

Main Risk Factors for Nephropathy in Type 2 Diabetes Mellitus Are Plasma Cholesterol Levels, Mean Blood Pressure, and Hyperglycemia

Mordchai Ravid, David Brosh, D Ravid-Safran et al. · Archives of Internal Medicine · 1998 · 453 citations · Full text

Medicine, Internal Medicine, Nephrology +14

The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study

Rita Rachmani, Inna Slavachevsky, M Amit et al. · Diabetic Medicine · 2004 · 142 citations

Medicine, Endocrinology, Pharmacotherapy +14

Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications

Rita Rachmani, Inna Slavachevski, Zohar Levi et al. · European Journal of Internal Medicine · 2002 · 136 citations

Medicine, Endocrinology, Pharmacotherapy +13

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

R Lang, Rita Rachmani · PubMed · 1996 · 127 citations

Medicine, Pharmacology, Pharmacotherapy +17

Teaching patients to monitor their risk factors retards the progression of vascular complications in high‐risk patients with Type 2 diabetes mellitus—a randomized prospective study

Rita Rachmani, Zohar Levi, Inna Slavachevski et al. · Diabetic Medicine · 2002 · 112 citations

Medicine, Family Medicine, Internal Medicine +17